Statistics + Epidemiology Flashcards

1
Q

Recall 2 x 2 table
- PPV
- NPV
- Specificity
- Sensitivity
- Pos likelihood ratio
- Neg likelihood ratio

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

2x2 table. How to calculate:
-RR
- OR
- NNT
- NNH

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is positive predictive value and how to calculate?

A

Positive predictive value
* Predictive value of test
* Chance if the est is positive of patient actually having the disease
- precision of test
* PPV = True positives / all the positives
PPV = T+ / (T+ + F+)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is negative predictive value and how to calculate?

A

Negative predictive value
* If the test is negative, what is the chance of patient actually not having the disease
* NPV = True negative outcome/ over all negative outcomes
NPV = T- / (T- + F-)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Sensitivity - what, how to calculate, when most useful?

A

Sensitivity
* True positive rate of test
* Out of all people with condition, how many does test report is positive?
* Only concentrating on people with the condition (Condition +)
* Sensitivity = True positives / (true positives + false negatives)
* Test has high sensitivity - reports or overreports condition, unlikely to miss condition
Test has sensitivity, negative result is useful for ruling out disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Specificity - what, how to calculate, when most useful?

A

Specificity
* True negative rate
* Of all the people who don’t have condition, how many does the test report as negative
* Specificity = true negatives / (true negatives + false positives)
Test with high specificity, if have positive result useful to rule in disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Calculate positive predictive value from Sens/Spec/Prevalence
- steps involved

A

1) True positives
2) False positives
3) Positive predictive value

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Likelihood ratio + - what, how to calculate

A
  • Assess value of performing a diagnostic test
    • Uses sensitivity and specificity of test to determine whether a test result usefully changes the probability that a condition exists
    • Probability of a true positive (with disease) to false positives (without disease)
      • LR = sensitivity/ (100% - specificity)
        Positive likelihood ratio - larger big number, better, increases post test probability - worthwhile testLikelihood ratio of a positive test
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Likelihood ratio of negative test - what, how to calculate?

A

Likelihood ratio of negative test
* Probability of false negative (with disease) to a true negative (without disease)
LR - = (100% - sensitivity)/ specificity
Negative likelihood ratio - lower closer to 0, better, decreases post test probability, helpful to rule out - useful test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pre-test probability - what, how to calculate

A

Pre-test probability
* Probability of patient having disease before diagnostic test is known
* Essentially prevalence within subject population
Pre-test probability = proportion of patients with disease/all patients with the symptoms (with and without disorder)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Bias - confounding, ecological fallacy, selection, recall?

A

· Confounding - distortion in measure of risk factor and outcome by mixing effect with another exposure
· Ecological fallacy - not applying clinical decision instrument to patient in front of you
· Selection bias - group selected for study not representative wider population
Recall bias - do not correctly remember events in past

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is incidence?

A
  • Rate
    Eg cases per 5 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is prevalence?

A
  • “Point”/ cross section in time
    • Point prevalence studies
      Prevalence = Incidence x mean survival
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Screening tests - what do you want?

A
  • High sensitivity
    • High pos likelihood ratio - bigger number, increase post test probability
      Pos predictive value
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

WHO guidelines for screening? (Wilson’s criteria)

A
  • Important health problem
    • Need treatment
    • Facilities to diagnosis and treatment
    • Latent stage
    • Test or examination
    • Test acceptable to population
    • Natural history - adequately understand
    • Agreed policy on whom to treat
    • Cost, economical
      Continuous process
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Relative Risk?

A
  • RR = a/(a+b)/ c/ (c+d)
    • Ratio of outcome between two exposures or treatments
    • Probability of an event occurring in exposed group compared to the non exposed group
    • RCT/cohort studies
    • Incidence rate exposed/ incidence rate unexposed
    • RR = 1 = 1 same
    • RR > 1- increased risk in exposed
      RR < 1 - decreased risk in exposed
17
Q

Odds Ratio?

A
  • Event occurring: event not occurring
    • Compared to probability - event occurring/ total events
    • Odds and probability of having a girl or boy
    • Odds = 1:1, probability 0.5

OR = (a/b)/ (c/d) = ad/cb

* Used when population risk unknown in case-control studies  With low prevalence, OR~ RR (mathematically)
18
Q

Absolute risk reductions vs relative risk reduction?

A

Absolute Risk Reduction
* Population change
* Real difference in absolute terms between the two exposure or treatment groups
* Absolute risk reduction = events in control/total control - events in treatment/total treatment

* In above - relative risk 50% reduction (what drug companies like quoting) Absolute risk reduction - 20% die to 10% die = 10% (actual 10% difference)
19
Q

Number needed to treat?

A
  • How many patients needed to be treated to prevent one event
    NNT = 1/ (probability in exposed - probability in non exposed)
    NNT = 100/absolute risk reduction (%)
    NNT = 100/10 = 10
20
Q

Number needed to harm?

A

NNH = 100 /absolute risk increase (%)

21
Q

Type 1 error (alpha error)?

A
  • Alpha error
    • False positive
    • Pick up significant difference when there ISN’T one
    • Reject null hypothesis when it is actually true
    • Report your findings are significant when they have occurred by chance
    • Alpha = probability of making Type 1 error
    • Usually set at 0.05
      Reduce by: randomisation, blinding
22
Q

Type II error (beta error)?

A
  • False negative
    • Failing to reject a null hypothesis when it should have been rejected
    • MISS a significant difference then there is one there
    • Reduce by: larger sample size, power
    • Concludes no significant effect when actually there is
      Greatest chance of falsely rejecting a good treatment (type II error) is when the study is underpowered - need to good enough sample size
23
Q

Phase 1 drug design?

A

initial safety
* Small number, healthy
* Is it safe? Safety, toxicity, PK
* Aim = safety
* Often (n=20-100) healthy volunteers to determine safe dosing ranges, identify some adverse events/side effects
* Subjects observed for several half lives
Safe dosing range

24
Q

Phase II?

A
  • Small number with disease, efficacy, optimal dosing, adverse affects
    • IIA - dose
    • IIB - efficacy
    • Few hundred participants
      Some complete IIA and IIB together - efficacy and toxicity
25
Q

Phase III?

A

safety/efficacy compared to gold standard
* Aim - confirmation of safety and efficacy
* Large number, RCH, randomly assigned to placebo/best available treatment
* N = 100s to 1000s
* Confirm effectiveness vs placebo/active treatments “gold standard”
* Safety and efficacy and side effects compared to gold standard
* RCTs - often > 1
Involvement of regulators FDA/EMA to obtain approval

26
Q

Phase IV?

A

(post marketing surveillance)
* Post marketing surveillance after approved, rare/long term side effects
* Aim - continual pharmaco-viligance
* New uses/populations
* Often paediatric patients at this stage
* Larger populations, less controlled
* Longer follow up
Interactions with other medications

27
Q

Main study designs?

A

Systematic review/meta-analysis
* Most reliable

RCT
* Least biased- randomisation
* Can prove causality
* Intervention vs placebo

Cohort
* Have group of people with an exposure, measure for lots of different outcomes
* Observational assoc not causality
* Exposure vs non exposure
* Prospective vs retrospective
* RR > 3

Case Control
* Disease vs no disease
* Look back at exposures
* Observational assoc not causality
* Good for rare numbers
* Small number
* Most biased
* OR > 4

Cross sectional
* Frequency of disease and risk factors at particular point in time
* Risk factor association not causality
* Prevalence

Case Series/reports

28
Q

Normal distribution SD numbers?

A
  • 1SD = 68%
    • 2 SD = 95%
    • 3SD = 99.7%
29
Q

Confidence Intervals?

A
  • 95% CI = p 0.05
    • If 95% CI includes 1 - NOT stat signif
    • If CI between 2 groups overlaps - NOT stat signif
    • If CI between 2 groups don’t overlap - sig sif
      Narrower CI - more precise